Eurofins Scientific Nante (ERFSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 664,301 | 1,321,705 | 512,682 | 609,651 | 1,042,234 |
| Marketable Securities | 2,164 | 4,654 | 5,900 | 592 | 114 |
| Receivables | 1,294,300 | 1,289,128 | 1,252,625 | 1,335,128 | 1,159,092 |
| Inventories | 153,550 | 150,440 | 153,404 | 182,434 | 179,341 |
| Other current assets | 331,231 | 333,023 | 303,753 | 399,178 | 279,864 |
| TOTAL | $2,653,526 | $3,318,765 | $2,437,293 | $2,743,609 | $2,876,540 |
| Non-Current Assets | |||||
| PPE Net | 2,769,959 | 2,486,476 | 2,283,889 | 2,164,955 | 1,799,008 |
| Investments And Advances | 127,039 | 90,480 | 88,081 | 96,659 | 64,654 |
| Intangibles | 6,090,600 | 5,787,491 | 5,734,956 | 5,928,278 | 4,968,091 |
| Other Non-Current Assets | 140,998 | 101,520 | 79,757 | 107,543 | 87,500 |
| TOTAL | $9,128,596 | $8,465,967 | $8,186,683 | $8,297,435 | $6,919,253 |
| Total Assets | $11,782,340 | $11,784,730 | $10,623,980 | $11,041,040 | $9,795,794 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 518,110 | 650,571 | 225,260 | 300,271 | 271,411 |
| Accounts payable and accrued liabilities | 698,928 | 649,596 | 682,417 | 742,514 | 619,127 |
| Other current liabilities | 1,028,103 | 967,252 | 923,059 | 1,051,066 | 950,965 |
| TOTAL | $2,283,448 | $2,296,316 | $1,867,190 | $2,195,479 | $1,937,798 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,388,596 | 3,599,297 | 3,278,593 | 2,958,105 | 3,332,318 |
| Other Non-Current Liabilities | 165,886 | 212,564 | 231,054 | 207,161 | 147,585 |
| TOTAL | $3,671,998 | $3,928,208 | $3,645,772 | $3,311,970 | $3,612,752 |
| Total Liabilities | $5,955,554 | $6,224,524 | $5,512,962 | $5,507,449 | $5,550,550 |
| Shareholders' Equity | |||||
| Common Shares | 2,056 | 2,056 | 2,002 | 2,248 | 2,170 |
| Retained earnings | 2,913,230 | 2,590,810 | 2,458,049 | 2,324,082 | 1,496,984 |
| Other shareholders' equity | 3,244,498 | 3,026,342 | 2,665,963 | 3,211,265 | 2,746,090 |
| TOTAL | $5,826,784 | $5,560,208 | $5,111,014 | $5,533,595 | $4,245,244 |
| Total Liabilities And Equity | $11,782,338 | $11,784,732 | $10,623,976 | $11,041,044 | $9,795,794 |